Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 4 Open-market sale General Counsel sold 2,000 shares at an average $35.93 ($71,860)
  3. 4 Open-market sale General Counsel sold 3,200 shares at $35.25 ($112,800)
  4. 4 Open-market sale Chief Scientific Officer sold 1,600 shares at $35.00 ($56,000)
  5. 4 Open-market sale Chief Scientific Officer sold 400 shares at $32.34 ($12,936)
  6. 3 Insider Initial Statement of Ownership
  7. 4 Open-market sale General Counsel sold 1,200 shares at $29.87 ($35,845)
  8. 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $29.86 ($223,926)
  9. 4 Open-market sale Chief Scientific Officer sold 400 shares at $31.21 ($12,484)
  10. 4 Open-market sale General Counsel sold 1,200 shares at $27.00 ($32,400)
  11. 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $23.92 ($179,419)
  12. 4 Open-market sale Chief Scientific Officer sold 400 shares at $26.76 ($10,704)
  13. 4 Open-market sale General Counsel sold 1,200 shares at an average $29.40 ($35,282)
  14. 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $29.37 ($220,248)
  15. 4 Open-market sale Chief Scientific Officer sold 400 shares at $27.74 ($11,096)
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 11 of 14 · 274 filings